Piopar-MF 7.5 Tablet SR
By Piopar-MF
Rx
10 Tablet SR in a Strip

Composition
Pioglitazone(7.5mg) + Metformin(500mg)

Manufacturer - Mitoch Pharma Pvt Ltd
F19, F20, F21, Kohinoor Mall, Opp. Don Bosco Engineering College, Kirol Road, Kurla (W), Mumbai - 400 070

Expires on or after
May, 2027

liver
When taking Piopar-MF 7.5 Tablet SR, it's important to be cautious if you have liver disease. Patients with liver issues may require a dose adjustment for this medication. It is advised to start with a low dose if you have mild to moderate liver disease. However, Piopar-MF 7.5 Tablet SR is not recommended for individuals with severe liver disease. Always consult your doctor before using this medication if you have any liver conditions.

kidney
Piopar-MF 7.5 Tablet SR may require dose adjustment in kidney disease patients. Not recommended in severe kidney disease. Regular kidney function tests advised during use. Consult your doctor.

alcohol
It is unsafe to consume alcohol with Piopar-MF 7.5 Tablet SR. Avoid alcohol while taking this medication.

driving
When taking Piopar-MF 7.5 Tablet SR, be cautious while driving as low or high blood sugar levels can impact your ability to drive safely. Refrain from driving if experiencing symptoms affecting focus and reaction time.

pregnancy
Piopar-MF 7.5 Tablet SR should be used with caution during pregnancy. Limited human studies indicate potential harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. Please consult your doctor.

breastfeeding
Caution should be taken while breastfeeding if taking Piopar-MF 7.5 Tablet SR as it is believed to be unsafe during this period. Limited data indicates the drug might pass into breastmilk and potentially harm the baby.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | ANTI DIABETIC |
| Action Class | - |
₹46.75
₹55
15% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 11-Feb-2025
